These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 7515732

  • 1. [Use of fluorine-19 nuclear resonance spectroscopy for the measurement of changes induced in blood perfusion volume in experimental tumors in vivo].
    Thomas C, Counsell C, Wood P, Adams G.
    Bull Cancer; 1993 Aug; 80(8):666-73. PubMed ID: 7515732
    [Abstract] [Full Text] [Related]

  • 2. Use of fluorine-19 nuclear magnetic resonance spectroscopy and hydralazine for measuring dynamic changes in blood perfusion volume in tumors in mice.
    Thomas C, Counsell C, Wood P, Adams GE.
    J Natl Cancer Inst; 1992 Feb 05; 84(3):174-80. PubMed ID: 1542128
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance spectroscopy studies on experimental murine and human tumors: comparison of changes in phosphorus metabolism with induced changes in vascular volume.
    Adams GE, Bremner JC, Counsell CJ, Stratford IJ, Thomas C, Wood PJ.
    Int J Radiat Oncol Biol Phys; 1992 Feb 05; 22(3):467-71. PubMed ID: 1735680
    [Abstract] [Full Text] [Related]

  • 4. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
    Aboagye EO, Maxwell RJ, Kelson AB, Tracy M, Lewis AD, Graham MA, Horsman MR, Griffiths JR, Workman P.
    Cancer Res; 1997 Aug 01; 57(15):3314-8. PubMed ID: 9242466
    [Abstract] [Full Text] [Related]

  • 5. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
    Papadopoulou MV, Pouremad R, Bloomer WD, Wyrwicz A.
    Anticancer Res; 2006 Aug 01; 26(5A):3259-63. PubMed ID: 17094438
    [Abstract] [Full Text] [Related]

  • 6. Deuterium nuclear magnetic resonance imaging of tracer distribution in D2O clearance measurements of tumor blood flow in mice.
    Larcombe McDouall JB, Evelhoch JL.
    Cancer Res; 1990 Jan 15; 50(2):363-9. PubMed ID: 2153050
    [Abstract] [Full Text] [Related]

  • 7. In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.
    Procissi D, Claus F, Burgman P, Koziorowski J, Chapman JD, Thakur SB, Matei C, Ling CC, Koutcher JA.
    Clin Cancer Res; 2007 Jun 15; 13(12):3738-47. PubMed ID: 17575240
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced tumor oxygenation by treatment with vinblastine.
    Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Cemazar M, Auersperg M, Swartz HM.
    Cancer Res; 2001 May 15; 61(10):4266-71. PubMed ID: 11358854
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of tumour hypoxia by a vasoactive agent. A combined NMR and radiobiological study.
    Dunn JF, Frostick S, Adams GE, Stratford IJ, Howells N, Hogan G, Radda GK.
    FEBS Lett; 1989 Jun 05; 249(2):343-7. PubMed ID: 2737292
    [Abstract] [Full Text] [Related]

  • 17. Reduced blood flow increases the in vivo ammonium ion concentration in the RIF-1 tumor.
    Constantinidis I, Gamcsik MP.
    Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):143-9. PubMed ID: 7642412
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography.
    Aboagye EO, Kelson AB, Tracy M, Workman P.
    Anticancer Drug Des; 1998 Sep 30; 13(6):703-30. PubMed ID: 9755726
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.